enVVeno Medical Corporation
NASDAQ Capital MarketTotal Valuation
enVVeno Medical Corporation carries a market capitalization of 73.65M, placing it among publicly traded companies globally. Its enterprise value stands at -30.16M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 73.65M |
| Enterprise Value | -30.16M |
Share Statistics
enVVeno Medical Corporation currently has 577,600.00 shares outstanding.
| Shares Outstanding | 577,600.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
enVVeno Medical Corporation maintains a current ratio of 13.12, meaning it holds 13.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 13.12 |
| Quick Ratio | 12.90 |
| Debt / Equity | 2.69 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -53.09 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
enVVeno Medical Corporation's stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.09.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.09 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -23.09M, while operating income came in at -23.58M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -23.58M |
| Pretax Income | -21.96M |
| Net Income | -21.96M |
| EBITDA | -23.09M |
| EBIT | -23.58M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
enVVeno Medical Corporation holds 30.95M in cash and equivalents against 791,000.00 in total debt, resulting in a net debt position of -1.54M. Total book value stands at -167.59M, with working capital of 29.10M providing operational flexibility.
| Cash & Cash Equivalents | 30.95M |
| Total Debt | 791,000.00 |
| Net Debt | -1.54M |
| Equity (Book Value) | -167.59M |
| Book Value Per Share | N/A |
| Working Capital | 29.10M |
Cash Flow
enVVeno Medical Corporation produced -17.23M in operating cash flow over the past twelve months.
| Operating Cash Flow | -17.23M |
| Capital Expenditures | -9,000.00 |
| Free Cash Flow | -17.24M |
| FCF Per Share | N/A |
Scores
enVVeno Medical Corporation posts an Altman Z-Score of -8.58, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -8.58 |